The broad goal of the therapeutics theme is to conduct basic and translational research into human disease that will ultimately lead to new therapies. Our research investigates several areas where there is a need for improved medical care or there are emerging medical technologies that can be applied to different diseases.
The neuroscience group has a broad interest in developing therapies for neurodegenerative disease, spinal cord injury and stroke.
The cancer group seeks to develop novel therapies and biomarkers for cancer treatment and diagnosis and the translation of radiotherapy and drug therapy into clinical use.
The Nanopharmaceutics group at Keele is developing novel and innovative strategies to overcome difficult boundaries often faced in drug delivery. They design and formulate nanomedicines for a range of clinical conditions.
This group conducts a range of research including epidemiological studies, medicines optimisation analysis, decision support systems and pharmacy education.
Additional areas of interest:
We are conduct research into drug delivery across the skin, genetic epidemiology, malaria, fertility and blood coagulation.
Therapeutics Theme Leader: Dr Alan Richardson Therapeutics Theme Members
New laboratory research points way to how statins could be more effective in treatment of ovarian cancer
Posted on 14 July 2017
A new study led by Keele University has shown how statins may be used as a potentially effective treatment against ovarian cancer.
Much more than just hot air - Prof Josep Sule-Suso's inaugural lecture
Posted on 16 June 2017
Professor Josep Sule-Suso delivered his inaugural lecture on Breath Analysis in Cancer Management on 12 June.
"Why do scientists do what scientists do?" outreach website goes live
Posted on 05 December 2016
"Why do scientists do what scientists do?" is a new website by Dr Alan Richardson. The aim of the website is to better inform public understanding about research.
Professor praised by hospital colleagues
Posted on 30 November 2016
Prof Josep Sulé-Suso has been praised by colleagues for his hard work on a home-grown Radiotherapy study
Building bridges through Science: congress in Iran
Posted on 02 September 2016
Dr David Mottershead was invited to speak at the Royan International Twin Congress in Tehran, Iran building on new links with researchers at the Royan Institute.
Cumulin in the news
Posted on 24 August 2016
Research on the protein Cumulin has featured in news around the world this week, in an emerging infertility treatment as a less invasive and cheaper alternative to IVF
New BHF award to Prof Glenn Morris and Dr Ian Holt
Posted on 13 July 2016
Professor Glenn Morris and Dr Ian Holt have been awarded a new grant from the British Heart Foundation for £233,316 for a project to examine the role of nuclear envelope proteins in cardiac conduction and heart disease.
Major funding boost for Stroke Research
Posted on 11 July 2016
Professor Christine Roffe has been awarded just under £2.5 million from the NIHR for Stroke Research.
Seminar on polymers by Chinese visitor
Posted on 24 June 2016
Professor Haichen Wu, from the Chinese Academy of Sciences, visited the GHRC to speak to ISTM members about his work on conjugated polymers.
Pathfinder award from the Wellcome Trust
Posted on 18 March 2016
Dr Alan Richardson, ISTM and School of Pharmacy, has been awarded an 18 month grant from the Wellcome Trust for his project "Discovery of autophagy inhibitors by blocking the Atg5-Atg16 interaction"
Wellcome Seed Award in Science for pharmacology research
Posted on 05 February 2016
Dr Ruoli ("Ronnie") Chen has been awarded nearly £90,000 for an 18-month project on "Pharmacological accumulation of hypoxia inducible factors for neuroprotection in cerebral ischaemia".
Building a bespoke bioluminescence microscope
Posted on 17 February 2017
Professor Melissa Mather’s research group has constructed a tailor-made bioluminescence microscope for another team in the Research Institute for Science & Technology in Medicine.